Sylvie Chevret

Affiliations: 
UPMC Univ Paris 6, France 
Google:
"Sylvie Chevret"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lambert J, Di Blasi R, Rabian F, et al. (2023) Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data. Hemasphere. 7: e873
Vanier A, Fernandez J, Kelley S, et al. (2023) Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health. Bmj Evidence-Based Medicine
Lambert J, Lengliné E, Porcher R, et al. (2022) Enriching single-arm clinical trials with external controls: possibilities and pitfalls. Blood Advances
Biard L, Bergeron A, Lévy V, et al. (2021) Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials. Contemporary Clinical Trials Communications. 21: 100709
Fenwarth L, Thomas X, de Botton S, et al. (2020) A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia. Blood
Azabou E, Bao G, Heming N, et al. (2020) Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol. Frontiers in Medicine. 7: 372
Faucheux L, Resche-Rigon M, Curis E, et al. (2020) Clustering with missing and left-censored data: A simulation study comparing multiple-imputation-based procedures. Biometrical Journal. Biometrische Zeitschrift
Bridoux F, Arnulf B, Karlin L, et al. (2020) Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000298
Zerbit J, Chevret S, Bernard S, et al. (2020) Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study. Annals of Hematology
Azoulay E, Zafrani L, Mirouse A, et al. (2020) Clinical phenotypes of critically ill COVID-19 patients. Intensive Care Medicine
See more...